Signaling pathways, microenvironment, and targeted treatments in Langerhans cell histiocytosis.

Abstract excerpt

Langerhans cell histiocytosis (LCH) is an inflammatory myeloid malignancy in the "L-group" histiocytosis. Mitogen-activated protein kinase (MAPK) pathway activating mutations are detectable in nearly all LCH lesions. However, the pathogenic roles of MAPK pathway activation in the development of histiocytosis are still elusive. This review will summarize research concerning the landscape and pathogenic roles of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Histiocytosis, Langerhans-Cell
• Share to MAP Kinase Signaling System